T.TH
|
My understanding is that the grading system is from 1 to 4. So, grade 5...
|
T.TH
|
My wife currently is on Niraparib, a parp inhibitor for recurrent ovarian...
|
T.TH
|
Can you tell me what the ROI has been since Paul became CEO? Momo25 wrote: I...
|
T.TH
|
Thanks,that makes a lot of sense. (What Wino wrote also) I believe most of...
|
T.TH
|
Trying to calculate # of patients in 1a. So, 65 patients overall. In...
|
T.TH
|
Personally, I am not feeling very optimistic about the trial. ...
|
T.TH
|
Thanks, yes that helps a lot. qwerty22 wrote: It's difficult from the...
|
T.TH
|
A couple of question for those who might know more about this. 1) If MTD is...
|
T.TH
|
Yes, that makes sense. You know when I first read your post, a...
|
T.TH
|
If not the FDA then who convinced Thera to go for General rather than HIV...
|
T.TH
|
Jfm1330, I like your actinium-225 idea. It can probably overcome any...
|
T.TH
|
In order to be commercially successful TH-1902 will have to have better...
|
T.TH
|
My issue with using Taxol is that Taxol works well with rapidly dividing...
|
T.TH
|
I believe it is a pretty standard premed for chemo, in particular for taxol...
|
T.TH
|
I am sorry to hear that, I know you had told me that she had an...
|
T.TH
|
From what I understand of Sortilin is that it is a receptor highly associated...
|
T.TH
|
Initially Th1902 was for TNBC and Th1904 for Ovarian cancer. But then...
|
T.TH
|
There are other mechanisms of resistance. The 2 I am most concerned...
|
T.TH
|
Maybe. But if the cancer trial does really well and the market responds...
|
T.TH
|
My wife is being treated at Princess Margaret Hospital for Ovarian Cancer...
|